Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Shenzhen Hepalink Pharmaceutical Qtrly Net Profit Attributable RMB127.5 Mln

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    29/10/2020 10:50
    Oct 29 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co
Ltd  002399.SZ :
    * QTRLY NET PROFIT ATTRIBUTABLE RMB127.5 MILLION, UP 2.13%
    * QTRLY OPERATING REVENUE RMB883.3 MILLION, DOWN 12.56%
    * API BUSINESS EXPECTED TO RETURN TO NORMAL GRADUALLY IN Q4

Source text for Eikon:  ID:nHKS9wTFTW 
Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news